LON:DRS

17314 (DRS.L) Share Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume3,661 shs

Average Volume2,082 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive DRS News and Ratings via Email

Sign-up to receive the latest news and ratings for 17314 (DRS.L) and its competitors with MarketBeat's FREE daily newsletter.

About 17314 (DRS.L)

DRS Data and Research Services plc is a holding company. The Company is a provider of automated data capture technology and solutions in the United Kingdom. The Company's business consists of Education and non Education. Its Education comprises Examination & Assessment, and Other. Its non Education comprises Commercial and Elections & Census. The Company is engaged in the provision of software, data capture services, the manufacture, sale and support of optical and image scanning equipment, design and printing of documentation used for data capture and bureau services. The Company provides an end-to-end solution for electronically counted elections, including form design and printing, hardware, software, project support and training. The Company provides data capture solutions for censuses, including paper-based national or regional population censuses and specialized industrial, commercial and agricultural censuses. The Company's subsidiary is DRS Data Services Limited.

Leading the Way by Sponsoring Cannabinoid Research
October 21, 2020 | markets.businessinsider.com

Science Center for Marine Fisheries: SCEMFIS Research Provides New Insights on Gray Seals; Suggests Alternatives to Current Management
September 28, 2020 | finanznachrichten.de

Global Thermopile Microbolometer Infrared Detector Market 2020 Status and Outlook, Industry Growth Rate, Opportunities and Challenges to 2025
September 28, 2020 | marketwatch.com

Testing the Covid Vaccines and Credibility
September 24, 2020 | wsj.com

ADISA Co-Sponsored Academic Study Shows Real Estate Reliance on IRC Section 1031
September 16, 2020 | finance.yahoo.com

Global DoD Architecture Framework Market Proposal Strategy, PESTEL Analysis and Volume (2020-2029)|| Lockheed Martin Corporation, Boeing, Raytheon
September 14, 2020 | marketwatch.com

Vaccine developers hustle to meet FDA data requirements to submit for approval
September 11, 2020 | msn.com

US coronavirus: Get tested if you socialized over Labor Day, Dr. Deborah Birx said
September 11, 2020 | msn.com

Taiwan's Chung Shan Medical University Hospital Joins TriNetX to Streamline Research and Accelerate Data Analysis
September 11, 2020 | finance.yahoo.com

Xtelligent Healthcare Media Launches Healthcare Virtual Summit Series
September 10, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Electronic Computer Manufacturing
Sub-Industry: N/A
Sector: Manufacturing
Current Symbol: LON:DRS
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.drs.co.uk
Phone: +44-1908-666088
Employees: 6,650
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 17314 (DRS.L).

4.4 Community Rank

Outperform Votes
17314 (DRS.L) has received 73 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
17314 (DRS.L) has received 39 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
17314 (DRS.L) has received 65.18% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about 17314 (DRS.L) and other stocks. Vote “Outperform” if you believe DRS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DRS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
17314 (DRS.L) does not currently pay a dividend.
Dividend Growth
17314 (DRS.L) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 17314 (DRS.L) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

17314 (DRS.L) (LON:DRS) Frequently Asked Questions

What stocks does MarketBeat like better than 17314 (DRS.L)?: Wall Street analysts have given 17314 (DRS.L) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 17314 (DRS.L) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are some of 17314 (DRS.L)'s key competitors?: Some companies that are related to 17314 (DRS.L) include S&P SmallCap 600/Citigroup Growth Index (CKG), (AURR.L) (AURR), (BAV.L) (BAV), (BNNP) (BNNP), (BVII) (BVII), (CBNR) (CBNR), (DGTC) (DGTC), (DTOR) (DTOR), (EDW.V) (EDW), (EFLO) (EFLO), (FOHL) (FOHL), (FSN.V) (FSN), (FTE.V) (FTE), (GFIR.L) (GFIR) and (HHVT.L) (HHVT).
View all of DRS's competitors.
What is 17314 (DRS.L)'s stock symbol?: 17314 (DRS.L) trades on the London Stock Exchange (LON) under the ticker symbol "DRS."
How do I buy shares of 17314 (DRS.L)?: Shares of DRS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
How many employees does 17314 (DRS.L) have?: 17314 (DRS.L) employs 6,650 workers across the globe.
What is 17314 (DRS.L)'s official website?: The official website for 17314 (DRS.L) is www.drs.co.uk.
Where are 17314 (DRS.L)'s headquarters?: 17314 (DRS.L) is headquartered at 1 Danbury Court, MILTON KEYNES, MK14 6LR, United Kingdom.
How can I contact 17314 (DRS.L)?: 17314 (DRS.L)'s mailing address is 1 Danbury Court, MILTON KEYNES, MK14 6LR, United Kingdom. The company can be reached via phone at +44-1908-666088.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.